MYC and cancer: We first determined the effect of MB2 residue substitution and S146L on MYC:TRRAP binding, postulating that due to the proximity of this residue to MB2 and its recurrence in cancer, it may induce a gain-of-function by modifying TRRAP binding to MYC.